Latest Investor Relations News

BCAL Diagnostics reported a slight revenue decline and a persistent net loss in its half-year results, with auditors flagging concerns over its ability to continue without additional funding.

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

Aumega Metals has voluntarily suspended its ASX securities as it finalises a capital raising involving a significant new investor. The suspension is expected to last until the capital raising is completed and announced, or until trading resumes on 19 February.

Contact Energy has successfully completed a NZ$450 million placement as part of a NZ$525 million equity raise, supported by both existing and new international investors. The company now opens a NZ$75 million retail offer to eligible shareholders, marking a significant capital expansion.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

TradeWindow has successfully closed its NZ$5.9 million Share Purchase Plan, with retail investors contributing around NZ$217,000. Shares will be allotted at NZ$0.25 each, matching the previous placement price.

Swoop Holdings has completed the placement of its entitlement offer shortfall, raising an additional $0.7 million and bringing total proceeds to $10 million. Notably, non-executive directors have subscribed for half of the shortfall shares, pending shareholder approval.

Aurizon Holdings reported a 9% rise in underlying EBITDA to $891 million for the half-year ending December 2025, driven by higher volumes and yields in coal and bulk segments. The company also raised its full-year dividend guidance and extended its share buy-back program.

Nick Scali Limited has announced a fully franked ordinary dividend of AUD 0.39 per share for the six months ending 31 December 2025, signalling steady returns for shareholders.